Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer ...

For patients with moderately to severely active ulcerative colitis, oral icotrokinra, a peptide that blocks the ...

In a world-first international trial, adding intismeran, a type of personalized therapeutic cancer vaccine made from each ...

Research published today identifies potential new ways to treat the most common type of colorectal cancer in Ireland. The ...

Scientists at Trinity College Dublin have made a breakthrough in understanding how cancer cells can evade the cell-killing ...

Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is ...

For years, developers of virtual reality (VR) and augmented reality (AR) technologies have worked to address an unwanted side ...

Early results of the first clinical trial to evaluate the drug invikafusp alfa (invika) in humans indicate that the treatment ...

The activity of six different genes can help determine survival in patients with acute myeloid leukemia (AML), according to a ...

Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with ...

A new prospective study from Japan explored whether fish consumption before and during pregnancy is linked to hypertensive ...

The phase 2 BESTOW clinical trial showed that tegoprubart (a novel anti-CD40L antibody therapy) was better at preserving ...